Adherence to statin therapy: Why aren't we doing better?

被引：10

作者：

Sacks, FM

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA USA

[3] Harvard Univ, Sch Med, Div Cardiovasc, Boston, MA USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2002年 / 113卷 / 08期

关键词：

D O I：

10.1016/S0002-9343(02)01428-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：685 / 686

页数：2

共 14 条

[1] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .1. EFFICACY IN MODIFYING PLASMA-LIPOPROTEINS AND ADVERSE EVENT PROFILE IN 8245 PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA [J].

BRADFORD, RH ;

SHEAR, CL ;

CHREMOS, AN ;

DUJOVNE, C ;

DOWNTON, M ;

FRANKLIN, FA ;

GOULD, AL ;

HESNEY, M ;

HIGGINS, J ;

HURLEY, DP ;

LANGENDORFER, A ;

NASH, DT ;

POOL, JL ;

SCHNAPER, H .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :43-49

[2]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3] Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Additional perspectives on tolerability of long-term treatment with lovastatin [J].

Downs, JR ;

Clearfield, M ;

Tyroler, HA ;

Whitney, EJ ;

Kruyer, W ;

Langendorfer, A ;

Zagrebelsky, V ;

Weis, S ;

Shapiro, DR ;

Beere, PA ;

Gotto, AM .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (09) :1074-1079

[4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[5] Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice [J].

Frolkis, JP ;

Pearce, GL ;

Nambi, V ;

Minor, S ;

Sprecher, DL .

AMERICAN JOURNAL OF MEDICINE, 2002, 113 (08) :625-629

[6] Lipid lowering in a multidisciplinary clinic compared with primary physician management [J].

Harris, DE ;

Record, NB ;

Gipson, GW ;

Pearson, TA .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (07) :929-+

[7]

PEDERSEN TR, 1994, LANCET, V344, P1383

[8] Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering [J].

Pedersen, TR ;

Wilhelmsen, L ;

Færgeman, O ;

Strandberg, TE ;

Thorgeirsson, G ;

Troedsson, L ;

Kristianson, J ;

Berg, K ;

Cook, TJ ;

Haghfelt, T ;

Kjekshus, J ;

Miettinen, T ;

Olsson, AG ;

Pyörälä, K ;

Wedel, H .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (03) :257-262

[9] Safety and tolerability of pravastatin in long-term clinical trials - Prospective pravastatin pooling (PPP) project [J].

Pfeffer, MA ;

Keech, A ;

Sacks, FM ;

Cobbe, SM ;

Tonkin, A ;

Byington, RP ;

Davis, BR ;

Friedman, CP ;

Braunwald, E .

CIRCULATION, 2002, 105 (20) :2341-2346

[10] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

← 1 2 →